Global Hunter Securities Downgrades PDL BioPharma (PDLI) to Accumulate; Valuation Call
Tweet Send to a Friend
Global Hunter Securities downgraded PDL BioPharma (NASDAQ: PDLI) from Buy to Accumulate.
Global analyst says, "We continue to view PDLI ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Global analyst says, "We continue to view PDLI ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
